Mucin-1 and its relation to grade, stage and survival in ovarian carcinoma patients-Reference-Cited by-同舟云学术

Mucin-1 and its relation to grade, stage and survival in ovarian carcinoma patients

Published:2012-12 Issue:1 Volume:12 Page:
ISSN:1471-2407
Container-title:BMC Cancer
language:en
Short-container-title:BMC Cancer

Author:

Engelstaedter Verena,Heublein Sabine,Schumacher Anamur Lan,Lenhard Miriam,Engelstaedter Helen,Andergassen Ulrich,Guenthner-Biller Margit,Kuhn Christina,Rack Brigitte,Kupka Markus,Mayr Doris,Jeschke Udo

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics,Oncology

Link

http://link.springer.com/content/pdf/10.1186/1471-2407-12-600.pdf

Reference31 articles.

1. Cannistra SA: Cancer of the ovary. N Engl J Med. 2004, 351: 2519-2529. 10.1056/NEJMra041842.

2. Goff BA, Mandel LS, Melancon CH, Muntz HG: Frequency of symptoms of ovarian cancer in women presenting to primary care clinics. JAMA. 2004, 291: 2705-2712. 10.1001/jama.291.22.2705.

3. Omura GA, Brady MF, Homesley HD, Yordan E, Major FJ, Buchsbaum HJ, Park RC: Long-term follow-up and prognostic factor analysis in advanced ovarian canrcinoma: the gynecologic oncology group experience. J Clin Oncol. 1991, 9: 1138-1150.

4. Klee GG, Schreiber WE: MUC1 gene-derived glycoprotein assays for monitoring breast cancer (CA15–3, CA 27.29, BR): are they measuring the same antigen?. Arch Pathol Lab Med. 2004, 128: 1131-1135.

5. Kufe DW: Targeting the human MUC1 oncoprotein: A tale of two proteins. Cancer Biol Ther. 2008, 7: 81-84. 10.4161/cbt.7.1.5631.

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficient CAR T cell targeting of the CA125 extracellular repeat domain of MUC16;Journal for ImmunoTherapy of Cancer;2024-04

2. Aptamer Tethered Bio-Responsive Mesoporous Silica Nanoparticles for Efficient Targeted Delivery of Paclitaxel to Treat Ovarian Cancer Cells;Journal of Pharmaceutical Sciences;2023-05

3. Mucins as Potential Biomarkers for Early Detection of Cancer;Cancers;2023-03-07

4. Pt(II)-PLGA Hybrid in a pH-Responsive Nanoparticle System Targeting Ovarian Cancer;Pharmaceutics;2023-02-10

5. Radioimmunoconjugates in the age of modern immuno-oncology;Life Sciences;2022-12